Email this article Polymorphism of nitric oxide synthase genes (NOS1 84G/A AND NOS3 786C/T) in patients with bronchial asthma and essential hypertension
- Authors: Shakhanov A.V.1, Nikiforov A.A.1, Uryasyev O.M.1
-
Affiliations:
- Ryazan State Medical University
- Issue: Vol 25, No 3 (2017)
- Pages: 378-390
- Section: Internal medicine
- URL: https://journals.rcsi.science/pavlovj/article/view/7085
- DOI: https://doi.org/10.23888/PAVLOVJ20173378-390
- ID: 7085
Cite item
Abstract
There exists an interest in studying polymorphism of nitric oxide synthase genes in patients with bronchial asthma and essential hypertension.
Aim: to study clinical and pathogenetic significance of polymorphism of nitric oxide synthase genes (NOS1 84G/A and NOS3 786C/T) in formation of comorbid pathology of bronchial asthma and essential hypertension.
Materials and methods: in the study 71 patients participated who were treated for bronchial asthma or essential hypertension. The main group consisted of 24 patients with comorbid pathology of bronchial asthma and essential hypertension. The group of patients with isolated bronchial asthma included 23 individuals. The group of patients with isolated essential hypertension included 24 individuals. In all patients polymorphism of nitric oxide synthase genes NOS1 84G/A and NOS3 786C/T was determined.
Results: the studied groups did not differ in distribution of the genotypes (χ2=2.13, p=0.712) of NOS1 84G/A polymorphism. The studied groups reliably differed in distribution of alleles (χ2=10.55, p=0.005) and of separate genotypes (χ2=10.49, p=0.03) of NOS3 786C/T polymorphism which evidences the relationship between the given polymorphism and development of bronchial asthma and essential hypertension. In patients with comorbid pathology of bronchial asthma and essential hypertension the frequency of occurrence of T-allele is higher and that of C-allele is lower (χ2=4.24, p=0.04) than in patients with isolated bronchial asthma. T-allele of NOS3 786C/T polymorphism 2.4 times increases the probability for comorbid pathology of bronchial asthma and essential hypertension in comparison with isolated bronchial asthma (OR=2.40, 95% CI: 1.04-5.56).
Conclusion: evaluation of NOS3 786C/T polymorphism can be used for identification of patients with bronchial asthma with a high risk for development of essential hypertension.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. V. Shakhanov
Ryazan State Medical University
Author for correspondence.
Email: shakhanovav@gmail.com
очный аспирант кафедры факультетской терапии с курсами эндокринологии, клинической фармакологии, профессиональных болезней
Russian Federation, 9, Vysokovoltnaya str., Ryazan, 390026A. A. Nikiforov
Ryazan State Medical University
Email: shakhanovav@gmail.com
к.м.н., доцент, заведующий Центральной научно-исследовательской лабораторией
Russian Federation, 9, Vysokovoltnaya str., Ryazan, 390026O. M. Uryasyev
Ryazan State Medical University
Email: shakhanovav@gmail.com
д.м.н., профессор, заведующий кафедрой факультетской терапии с курсами эндокринологии, клинической фармакологии, профессиональных болезней
Russian Federation, 9, Vysokovoltnaya str., Ryazan, 390026References
- Belova IV, Kulagin OL, Zhestkov AV. Jepidemiologija sochetanija serdechno-sosudistyh zabolevanij i bronhial'noj astmy u vzroslyh pacientov (na primere goroda Novokujbyshevska) [Ep-idemiology of combination the cardiovascular diseases and bronchial asthma at adult patients (on the example of Novokuybyshevsk city)]. Izvestija Samarskogo nauchnogo centra Rossijskoj akad-emii nauk [News of the Samara Scientific Center of the Russian Academy of Sciences]. 2013; 15 (3-6): 1728-30. (in Russian)
- Ghosh S, Erzurum SC. Modulation of asthma pathogenesis by nitric oxide pathways and therapeutic opportunities. Drug discovery today. Disease mechanisms. 2012; 9 (3-4): e89-94.
- Aytekin M, Aulak KS, Haserodt S, Chakravarti R, Cody J, Minai OA et al. Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide. AJP: Lung Cellular and Molecular Physiology. 2012; 302 (6): L512-20.
- Belozerov VK, Rubanova MP, Veber VR, Gubskaja PM, Zhmajlova SV, Kulik NA. Jen-dotelijzavisimaja vazodilatacija i sostojanie stenki sonnoj arterii [Endothelium-dependent vasodila-tion and the condition of the carotid artery wall]. Kardiovaskuljarnaja terapija i profilaktika [Car-diovascular therapy and prevention]. 2014; 13 (S2): 16. (in Russian)
- Kumar R, Kohli S, Mishra A, Garg R, Alam P, Stobdan T et al. Interactions between the genes of vasodilatation pathways influence blood pressure and nitric oxide level in hypertension. American journal of hypertension. 2015; 28 (2): 239-47.
- Hernansanz-Agustín P, Izquierdo-Ál-varez A, García-Ortiz A, Ibiza S, Serrador JM, Mar-tínez-Ruiz A. Nitrosothiols in the immune system: signaling and protection. Antioxidants & redox signaling. 2013; 18 (3): 288-308.
- Uryasev OM, Rochagikov AI. Rol' oksida azota v reguljacii dyhatel'noj sistemy. [Role of nitric oxide in regulation of respiratory system] Nauka molodykh (Eruditio juvenium) [Science of young (Eruditio Juvenium)]. 2014; (2): 133-40. (in Russian)
- Kalinin RE, Gryaznov SV, Nikiforov AA, Kamaev AA, Shvalb AP, Slepnev AA. Po-limorfizm gena sintazy azota i jendotelina-1 pri hronicheskoj venoznoj nedostatochnosti nizhnih konechnostej [Nitric oxide synthase and endothelin-1 gene polymorphism in lower limb chronic venous insufficiency]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald]. 2015; (4): 97-102. (in Russian)
- Seidlerová J, Filipovský J, Mayer O Jr, Kučerová A, Pešta M, Seidlerová J et al. Associa-tion between endothelial NO synthase polymorphisms and arterial properties in the general popula-tion. Nitric Oxide. 2015; 44: 47-51.
